Tracer library / [211At]At-astatobenzamide-N-3-hydroxypropylidene-3

[211At]At-astatobenzamide-N-3-hydroxypropylidene-3

Also written as [At-211]astatobenzamide-N-3-hydroxypropylidene-3; [At-211]astato-benzamide-N-3-hydroxypropylidene-3

Radionuclide: At-211 t½ 431 min
Modality: Therapy
Production route: —
Stage: Preclinical
Syntheses indexed: 0

Bone metastases and bone lesions

What it is

Compound class: radiohalogenated amidobisphosphonate
Target / mechanism: bone mineral (hydroxyapatite)-binding bisphosphonate PMID 10628558
Clinical application: Endoradiotherapy of bone lesions using radiohalogenated bisphosphonates PMID 10628558
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [211At]At-astatobenzamide-N-3-hydroxypropylidene-3, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.